Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
InnoBio Fund
About
InnoBio is a French venture capital fund.
- Maisons-alfort,Ile-de-France,France
Highlights
Details
- Operating Status
- Active
- Investor Type
- Government Office,Venture Capital
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in the healthcare market.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 7, 2020
Diotheris
|
Seed | — | Biotechnology | Yes |
|
Aug 9, 2018
Millendo Therapeutics
|
Series Unknown | $30M | Biotechnology | — |
|
Mar 20, 2017
Advicenne
|
Series Unknown | €16M | Biotechnology | — |
|
Feb 24, 2017
TxCell
|
Post-IPO Equity | €11M | Biotechnology | — |
|
Jan 21, 2015
Sensorion
|
Series Unknown | €4M | Biopharma | — |
Exits
InnoBio Fund has had 8 exits. InnoBio Fund most notable exits include Advicenne , Genticel
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 6, 2017 | Advicenne | IPO | Biotechnology | Detail |
| Feb 28, 2017 | Genticel | M&A | Biotechnology | Detail |
| Apr 30, 2015 | Sensorion | IPO | Biopharma | Detail |
| Feb 13, 2015 | Poxel | IPO | Biotechnology | Detail |
| Jun 18, 2014 | Pixium Vision | IPO | 3D Technology | Detail |
